You are here

BieGene

A month after multi-billion dollar Novartis deal, BeiGene follows up with 'reverse' deal

Endpoints

Thu, 02/18/21 - 10:40 am

Boston Immune Technologies

Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More

Xconomy

Fri, 01/11/19 - 09:58 am

Juno Therapeutics

Kite Therapeutics

Agios Pharmaceuticals

Jounce Therapeutics